Literature DB >> 12757722

1H-Imidazo[4,5-c]quinoline derivatives as novel potent TNF-alpha suppressors: synthesis and structure-activity relationship of 1-, 2-and 4-substituted 1H-imidazo[4,5-c]quinolines or 1H-imidazo[4,5-c]pyridines.

Tomoyuki Izumi1, Jun Sakaguchi, Makoto Takeshita, Harumi Tawara, Ken-ichi Kato, Hitomi Dose, Tomomi Tsujino, Yoshinari Watanabe, Hideo Kato.   

Abstract

Structural modification of imiquimod (1), which is known as an interferon-alpha (IFN-alpha) inducer, for the aim of finding a novel and small-molecule tumor necrosis factor-alpha (TNF-alpha) suppressor and structure-activity relationship (SAR) are described. Structural modification of a imiquimod analogue, 4-amino-1-[2-(1-benzyl-4-piperidyl)ethyl-1H-imidazo[4,5-c]quinoline (2), which had moderate TNF-alpha suppressing activity without IFN-alpha inducing activity, led to a finding of 4-chloro-2-phenyl-1-[2-(4-piperidyl)ethyl]-1H-imidazo[4,5-c]quinoline (10) with potent TNF-alpha suppressing activity. The relation between conformational direction of 2-(4-piperidyl)ethyl group at position 1 and TNF-alpha suppressing activity is also demonstrated by NMR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757722     DOI: 10.1016/s0968-0896(03)00178-0

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  1-Isobutyl-N,N-dimethyl-1H-imidazo[4,5-c]quinolin-4-amine.

Authors:  Wan-Sin Loh; Hoong-Kun Fun; Reshma Kayarmar; S Viveka; G K Nagaraja
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-15

2.  In-silico molecular modelling, MM/GBSA binding free energy and molecular dynamics simulation study of novel pyrido fused imidazo[4,5-c]quinolines as potential anti-tumor agents.

Authors:  Upala Dasmahapatra; Chitluri Kiran Kumar; Soumyadip Das; Prathima Thimma Subramanian; Poornimaa Murali; Arnold Emerson Isaac; Karuppasamy Ramanathan; Balamurali Mm; Kaushik Chanda
Journal:  Front Chem       Date:  2022-09-30       Impact factor: 5.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.